Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical Study
Clinical trial NCT04831528 · UNKNOWN
Trial details
- NCT number
- NCT04831528
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-10
- Primary completion
- 2025-06-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.